AlbyPharma, previously recognized as Suir Pharma Ireland, is an established manufacturer with four decades of experience providing the European and US markets. It features the primary oral FDA-Approved Beta-Lactam facility in Europe, as well as Solid Dosage Form and Softgel manufacturing capabilities. The company also offers in-house R&D, Microlab, and analytical services. AlbyPharma is situated on 4.4 Hectares and comprises two manufacturing plants, each equipped with separate production cores, warehouses, and laboratories. Collaborating with AlbyPharma provides access to top-notch analytical services and capabilities, ensuring that partners have a clear purpose supported by the AlbyPharma team.